Goldman Sachs
ZYME icon

Goldman Sachs’s Zymeworks ZYME Stock Holding History

Goldman Sachs’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-103,600
Closed -$4.9M – 6398
2020
Q4 		$4.9M Buy
+103,600
New +$4.81M ﹤0.01% 3013

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs's ZYME Position: Q1 2026 in Review

Goldman Sachs increased its Zymeworks (ZYME) stake by 43% in Q1 2026, buying an estimated $4.24M and bringing the position to 599,486 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #2722.

Goldman Sachs first reported a position in ZYME in Q3 2018 and has held it in 26 quarters since. The position peaked at $41.3M in Q4 2021. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Goldman Sachs held 599,486 shares of Zymeworks worth $15M as of Q1 2026.
  • Goldman Sachs bought 179,279 Zymeworks shares in Q1 2026, an estimated $4.24M.
  • Zymeworks made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2722 holding.
  • Goldman Sachs first reported a position in Zymeworks in Q3 2018 and has held it in 26 quarters since.
  • Goldman Sachs's Zymeworks position peaked at $41.3M in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.